title: Oncogenomics and the development of new cancer therapies.
abstract: Scientists have sequenced the human genome and identified most of its genes. Now it is time to use these genomic data, and the high-throughput technology developed to generate them, to tackle major health problems such as cancer. To accelerate our understanding of this disease and to produce targeted therapies, further basic mutational and functional genomic information is required. A systematic and coordinated approach, with the results freely available, should speed up progress. This will best be accomplished through an international academic and pharmaceutical oncogenomics initiative.
authors.affiliation: Department of Mammalian Genomics, The Institute for Genomic Research, 9712 Medical Center Drive, Rockville, Maryland 2085, USA. RLS@tigr.org
authors.forename: Robert L
authors.initials: RL
authors.lastname: Strausberg
authors.forename: Andrew J G
authors.initials: AJ
authors.lastname: Simpson
authors.forename: Lloyd J
authors.initials: LJ
authors.lastname: Old
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Riggins
mesh_terms: D035843:Biomedical Research / Q000639:trends; D019295:Computational Biology; D023281:Genomics / Q000639:trends*; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy*; D009857:Oncogenes / Q000235:genetics*